Original Research
Published on 29 Jun 2022
Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance
in Cancer Molecular Targets and Therapeutics
- 3,324 views
- 3 citations
Original Research
Published on 29 Jun 2022
in Cancer Molecular Targets and Therapeutics
Correction
Published on 29 Jun 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 29 Jun 2022
in Cancer Molecular Targets and Therapeutics
Mini Review
Published on 29 Jun 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 28 Jun 2022
in Cancer Molecular Targets and Therapeutics
Brief Research Report
Published on 28 Jun 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 28 Jun 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 27 Jun 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 27 Jun 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 27 Jun 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Jun 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Jun 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 23 Jun 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 23 Jun 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 23 Jun 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 22 Jun 2022
in Cancer Molecular Targets and Therapeutics